The cytotoxic effect of MZ1-ACNPs on tumoral cells was assayed by monitoring their ability to inhibit cell growth using MTT assays in two cell lines representative of HER2+ breast cancer with different sensitivity to MZ1, SKBR3 (more resistant), and BT474 (more sensitive). The gene discussed is ERBB2; the disease is breast cancer.